Correlations of sialic acid with markers of inflammation, atherosclerosis and cardiovascular events in hemodialysis patients

被引:17
作者
Tseke, Paraskevi [1 ]
Grapsa, Eirini [1 ]
Stamatelopoulos, Kimon [3 ]
Samouilidou, Elizabeth [2 ]
Rammos, George [4 ]
Papamichael, Christos [3 ]
Zakopoulos, Nikolaos [4 ]
机构
[1] Univ Athens, Gen Hosp Alexandra, Renal Unit, Athens, Greece
[2] Univ Athens, Biochem Lab, Gen Hosp Alexandra, Athens, Greece
[3] Univ Athens, Vasc Lab, Gen Hosp Alexandra, Athens, Greece
[4] Univ Athens, Dept Clin Therapeut, Gen Hosp Alexandra, Athens, Greece
关键词
atherosclerosis; C-reactive protein; end-stage renal disease; inflammation;
D O I
10.1159/000124850
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Serum total sialic acid (S-TSA) is associated with atherosclerotic process in general population. The aim of our study was to evaluate possible correlations of S-TSA with markers of inflammation and atherosclerosis in hemodialysis (HD) patients. Methods: We involved 53 asymptomatic, nondiabetic HD patients and 28 healthy controls. Atherosclerosis was evaluated by carotid ultrasonography, estimating intima media wall thickness and wall to lumen ratio bilaterally. To confirm our findings, we performed a 32-month cohort study, during which cardiovascular (CV) events were analyzed in relation to S-TSA concentration. Results: HD patients had higher S-TSA compared to controls (adjusted OR: 1.04, p = 0.026). In HD patients, S-TSA independently correlated with hs-CRP (p ! 0.0001), lipoprotein(a) (p = 0.02), intima media wall thickness (p = 0.023) and wall to lumen ratio (p = 0.028). Increased S-TSA concentration was associated with more CV events (p = 0.03). Conclusions: Serum TSA seems to correlate with inflammation, accelerated atherosclerosis and CV events in nondiabetic HD patients, but more studies need to confirm our findings. Copyright (C) 2008 S. Karger AG, Basel.
引用
收藏
页码:261 / 266
页数:6
相关论文
共 32 条
[1]  
Afzali B, 2003, J NEPHROL, V16, P540
[2]   Cardiovascular disease in renal allograft recipients is associated with elevated sialic acid or markers of inflammation [J].
Bakri, RS ;
Afzali, B ;
Covic, A ;
Sriskantharan, R ;
Bharma-Ariza, P ;
Park, WH ;
Sriharan, M ;
Dalton, N ;
Wierzbicki, AS ;
Crook, MA ;
Goldsmith, DJA .
CLINICAL TRANSPLANTATION, 2004, 18 (02) :201-204
[3]   PLASMA SIALIC-ACID AND ACUTE-PHASE PROTEINS IN PATIENTS WITH MYOCARDIAL-INFARCTION [J].
CROOK, M ;
HAQ, M ;
HAQ, S ;
TUTT, P .
ANGIOLOGY, 1994, 45 (08) :709-715
[4]  
Crook M, 1998, CLIN SCI, V95, P53, DOI 10.1042/cs0950053
[5]   SERUM SIALIC-ACID AND ACUTE-PHASE PROTEINS IN TYPE-1 AND TYPE-2 DIABETES-MELLITUS [J].
CROOK, MA ;
TUTT, P ;
SIMPSON, H ;
PICKUP, JC .
CLINICA CHIMICA ACTA, 1993, 219 (1-2) :131-138
[6]   Plasma fibrinogen and its relationship to plasma sialic acid in non-insulin-dependent diabetes mellitus [J].
Crook, MA ;
Couchman, S ;
Tutt, P .
BLOOD COAGULATION & FIBRINOLYSIS, 1996, 7 (06) :586-589
[7]   Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes - The EURODIAB Complications Study [J].
Crook, MA ;
Pickup, JC ;
Lumb, PJ ;
Georgino, F ;
Webb, DJ ;
Fuller, JH .
DIABETES CARE, 2001, 24 (02) :316-322
[8]   C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease [J].
Danesh, J ;
Wheeler, JG ;
Hirschfield, GM ;
Eda, S ;
Eiriksdottir, G ;
Rumley, A ;
Lowe, GDO ;
Pepys, MB ;
Gudnason, V .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (14) :1387-1397
[9]  
ELIASSMALE S, 2007, ATHEROSCLEROSIS
[10]   Clinical epidemiology of cardiovascular disease in chronic renal disease [J].
Foley, RN ;
Parfrey, PS ;
Sarnak, MJ .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 32 (05) :S112-S119